In the last trading session, 49,346,928 shares of the Onconova Therapeutics, Inc.(NASDAQ:ONTX) were traded, and its beta was 2.37. Most recently the company’s share price was $1.56, and it changed around -$0.07 or -0.05% from the last close, which brings the market valuation of the company to $368.96 Million. ONTX currently trades at a discount to its 52-week high of $1.93, offering almost -23.72% off that amount. The share price’s 52-week low was $0.19, which indicates that the current value has risen by an impressive 87.82% since then. We note from Onconova Therapeutics, Inc.’s average daily trading volume that its 10-day average is 173.09 Million shares, with the 3-month average coming to 52.34 Million.
Onconova Therapeutics, Inc. stock received a consensus recommendation rating of Hold, based on a mean score of 2.7. If we narrow it down even further, the data shows that none out of 4 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, 3 recommended ONTX as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. Onconova Therapeutics, Inc. is expected to report earnings per share of -$0.03 for the current quarter.
Onconova Therapeutics, Inc. (NASDAQ:ONTX): Trading Information
Although ONTX has showed a red trend with a performance of -4.59% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $1.93 on Thursday, Feb 18 increased the stock’s daily price by 19.17%. The company’s shares are currently up 2.35% year-to-date, but still up 0.3448 over the last five days. On the other hand, Onconova Therapeutics, Inc. (NASDAQ:ONTX) is 1.2% up in the 30-day period. We can see from the shorts that 12.67 Million shares have been sold at a short interest cover period of 0.24 day(s).
The consensus price target as assigned by Wall Street analysts is $0.46, which translates to bears needing to reduce their stock price by -70.51% from its current value. Analyst projections state that ONTX is forecast to be at a low of $0.46 and a high of $0.46. In order for the stock price to hit the forecast high, the stock would need to surge -70.51% from its current level, while the stock would need to crash -70.51% from its current level to reach the projected low.
Onconova Therapeutics, Inc. (ONTX) projections and forecasts
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of $40Million in revenue for the current quarter. 1 analysts expect Onconova Therapeutics, Inc. to make $6.63 Million in revenue for the quarter ending March 01, 2021. The company’s sales for the same quarters a year ago were $50Million and $150Million respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -20%. Forecasts for the next quarter put sales growth at 4320%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 67.9%. Onconova Therapeutics, Inc. earnings are expected to increase by 70% in 2021, but the outlook is negative 0% per year for the next five years.
Onconova Therapeutics, Inc. (NASDAQ:ONTX)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 0.56% of Onconova Therapeutics, Inc. shares, and 11.21% of them are in the hands of institutional investors. The stock currently has a share float of 11.28%. Onconova Therapeutics, Inc. stock is held by 37 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Sep 29, 2020, it held 3.35% of the shares, which is about 6.93 Million shares worth $1.94 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Principal Financial Group, Inc., with 0.56% or 1.16 Million shares worth $541.45 Thousand as of Dec 30, 2020, holds the second largest percentage of outstanding shares.